Literature DB >> 3485499

C-reactive protein (CRP) levels in systemic lupus erythematosus (SLE).

L F Linares, J J Gomez-Reino, P E Carreira, L Morillas, I Ibero.   

Abstract

CRP levels in 194 serum samples from 43 SLE patients were measured. Patients with inactive disease have levels below 10 micrograms/ml; patients with active SLE have higher levels, but never over 50 micrograms/ml. In the presence of infection or inflammatory processes, regardless of the activity of SLE, the levels are significantly higher (p less than 0.05), and well over 50 micrograms/ml. Both active SLE patients and inactive SLE patients with local infections have levels between 10 micrograms/ml and 50 micrograms/ml. In this situation, the presence of anti-DNA antibodies strongly suggests disease activity (82% versus 9%, p less than 0.05). The clinical and physiopathological meaning of these findings is discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3485499     DOI: 10.1007/BF02030970

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  17 in total

1.  C-reactive protein in the chronic rheumatic diseases.

Authors:  A G S HILL
Journal:  Lancet       Date:  1951-11-03       Impact factor: 79.321

2.  Absence of prostaglandin stimulated increase in acute phase proteins in systemic sclerosis.

Authors:  J T Whicher; M F Martin; P A Dieppe
Journal:  Lancet       Date:  1980-11-29       Impact factor: 79.321

Review 3.  C-reactive protein in SLE.

Authors:  M B Pepys; J G Lanham; F C De Beer
Journal:  Clin Rheum Dis       Date:  1982-04

4.  C-reactive protein and the acute-phase response.

Authors:  I Kushner; H Gewurz; M D Benson
Journal:  J Lab Clin Med       Date:  1981-06

5.  Colonic perforations in systemic lupus erythematosus.

Authors:  T M Zizic; L E Shulman; M B Stevens
Journal:  Medicine (Baltimore)       Date:  1975-09       Impact factor: 1.889

6.  The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients.

Authors:  B H Bulkley; W C Roberts
Journal:  Am J Med       Date:  1975-02       Impact factor: 4.965

7.  Fever in systemic lupus erythematosus.

Authors:  N I Stahl; J H Klippel; J L Decker
Journal:  Am J Med       Date:  1979-12       Impact factor: 4.965

8.  Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant.

Authors:  M L Boey; C B Colaco; A E Gharavi; K B Elkon; S Loizou; G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-08

9.  Value of serum C-reactive protein measurement in the investigation of fever in systemic lupus erythematosus.

Authors:  G J Becker; M Waldburger; G R Hughes; M B Pepys
Journal:  Ann Rheum Dis       Date:  1980-02       Impact factor: 19.103

10.  Frequency of neoplasia in systemic lupus erythematosus and rheumatoid arthritis.

Authors:  R B Lewis; C W Castor; R E Knisley; G G Bole
Journal:  Arthritis Rheum       Date:  1976 Nov-Dec
View more
  8 in total

1.  Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohort.

Authors:  S P Ardoin; L E Schanberg; C Sandborg; E Yow; H X Barnhart; K l Mieszkalski; N T Ilowite; E von Scheven; A Eberhard; D M Levy; Y Kimura; E Silverman; S L Bowyer; L Punaro; N G Singer; D D Sherry; D McCurdy; M Klein-Gitelman; C Wallace; R Silver; L Wagner-Weiner; G C Higgins; H I Brunner; L K Jung; L Imundo; J B Soep; A M Reed
Journal:  Lupus       Date:  2010-10       Impact factor: 2.911

Review 2.  Inflammation in Polycystic Ovary Syndrome: underpinning of insulin resistance and ovarian dysfunction.

Authors:  Frank González
Journal:  Steroids       Date:  2011-12-08       Impact factor: 2.668

3.  C-reactive protein +1444CT (rs1130864) genetic polymorphism is associated with the susceptibility to systemic lupus erythematosus and C-reactive protein levels.

Authors:  Francieli Delongui; Marcell Allyson Batisti Lozovoy; Tatiana Mayiumi Veiga Iriyoda; Neide Tomimura Costa; Nicole Perugini Stadtlober; Daniela Frizon Alfieri; Tamires Flauzino; Isaias Dichi; Andréa Name Colado Simão; Edna Maria Vissoci Reiche
Journal:  Clin Rheumatol       Date:  2017-06-01       Impact factor: 2.980

4.  C-reactive protein is linked to lower cognitive performance in overweight and obese women.

Authors:  V Sweat; V Starr; H Bruehl; A Arentoft; A Tirsi; E Javier; A Convit
Journal:  Inflammation       Date:  2008-03-18       Impact factor: 4.092

5.  Genetic variation in C-reactive protein (CRP) gene may be associated with risk of systemic lupus erythematosus and CRP concentrations.

Authors:  P Betty Shih; Susan Manzi; Penny Shaw; Margaret Kenney; Amy H Kao; Franklin Bontempo; M Michael Barmada; Candace Kammerer; M Ilyas Kamboh
Journal:  J Rheumatol       Date:  2008-09-15       Impact factor: 4.666

6.  Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): LXI. Value of C-reactive protein as a marker of disease activity and damage.

Authors:  Ana M Bertoli; Luis M Vilá; John D Reveille; Graciela S Alarcón
Journal:  J Rheumatol       Date:  2008-11-01       Impact factor: 4.666

Review 7.  Anti-Pentraxin Antibodies in Autoimmune Diseases: Bystanders or Pathophysiological Actors?

Authors:  Benoit Brilland; Emeline Vinatier; Jean-François Subra; Pascale Jeannin; Jean-François Augusto; Yves Delneste
Journal:  Front Immunol       Date:  2021-02-16       Impact factor: 7.561

8.  Cytokines and chemokines as biomarkers of community-acquired bacterial infection.

Authors:  Michal Holub; David A Lawrence; Nancy Andersen; Alžběta Davidová; Ondřej Beran; Vilma Marešová; Pavel Chalupa
Journal:  Mediators Inflamm       Date:  2013-04-16       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.